Endothelial dysfunction in type 1 diabetes

被引:6
作者
Bertoluci, Marcello Casaccia [1 ,2 ]
Ce, Gislaine Vissoky [2 ,5 ]
Da Silva, Antonio Marcos V. [3 ,4 ]
Punales, Marcia K. C. [5 ]
机构
[1] Univ Fed Rio Grande do Sul, Dept Med Interna, Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande do Sul, Programa Pos Grad Ciencias Med, Porto Alegre, RS, Brazil
[3] Univ Santa Cruz do Sul, Porto Alegre, RS, Brazil
[4] Univ Fed Rio Grande do Sul, Programa Pos Grad Ciencias Biol, Porto Alegre, RS, Brazil
[5] Grp Hosp Conceicao, ICD, Porto Alegre, RS, Brazil
关键词
endothelial dysfunction; type; 1; diabetes; nitric oxide; atherosclerosis;
D O I
10.1590/S0004-27302008000200030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular complications are the main cause of mortality and morbidity in diabetes. Mechanisms involved in the development of micro and macrovascular disease are complex and partially understood, but invariably begin as a dysfunctional endothelium. Nitric oxide is an important regulator of endothelial function and the impairment of its activity is determinant of the endothelial dysfunction. In type 1 diabetes, many factors like acute, chronic and postprandial hyperglycemia, as well as the duration of diabetes or autonomic neuropathy and microalbuminuria are associated to endothelial dysfunction. Oxidative stress, polyol pathway activation, protein kinase C activation and the presence of advanced glycation rend-products are potential mechanisms involved in the development of endothelial dysfunction. Early detection of endothelial dysfunction has prognostic value for the. development of vascular complications and may be important in strategies for primary prevention of cardiovascular endpoints in type 1 diabetes.
引用
收藏
页码:416 / 426
页数:11
相关论文
共 85 条
  • [1] LIGHT- AND ELECTRON-MICROSCOPIC STUDY OF SKIN CAPILLARIES OF DIABETICS
    AAGENAES, O
    MOE, H
    [J]. DIABETES, 1961, 10 (04) : 253 - &
  • [2] A NEW TECHNIQUE FOR RECORDING COMPLIANCE OF HUMAN HAND VEINS
    AELLIG, WH
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (03) : 237 - 243
  • [3] Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
    Al Suwaidi, J
    Hamasaki, S
    Higano, ST
    Nishimura, RA
    Holmes, DR
    Lerman, A
    [J]. CIRCULATION, 2000, 101 (09) : 948 - 954
  • [4] ACE inhibitors improve endothelial function in type 1 diabetic patients with normal arterial pressure and microalbuminuria
    Arcaro, G
    Zenere, BM
    Saggiani, F
    Zenti, MG
    Monauni, T
    Lechi, A
    Muggeo, M
    Bonadonna, RC
    [J]. DIABETES CARE, 1999, 22 (09) : 1536 - 1542
  • [5] Oral antioxidant therapy improves endothelial function in Type 1 but not Type 2 diabetes mellitus
    Beckman, JA
    Goldfine, AB
    Gordon, MB
    Garrett, LA
    Keaney, JF
    Creager, MA
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 285 (06): : H2392 - H2398
  • [6] Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
  • [7] MEASURING FOREARM BLOOD-FLOW AND INTERPRETING THE RESPONSES TO DRUGS AND MEDIATORS
    BENJAMIN, N
    CALVER, A
    COLLIER, J
    ROBINSON, B
    VALLANCE, P
    WEBB, D
    [J]. HYPERTENSION, 1995, 25 (05) : 918 - 923
  • [8] Plasma glucose levels throughout the day and HbA1c interrelationships in type 2 diabetes -: Implications for treatment and monitoring of metabolic control
    Bonora, E
    Calcaterra, F
    Lombardi, S
    Bonfante, N
    Formentini, G
    Bonadonna, RC
    Muggeo, M
    [J]. DIABETES CARE, 2001, 24 (12) : 2023 - 2029
  • [9] Biochemistry and molecular cell biology of diabetic complications
    Brownlee, M
    [J]. NATURE, 2001, 414 (6865) : 813 - 820
  • [10] BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315